Board of Directors
Defining alliance excellence.
The ASAP Board of Directors shapes the future of alliance management as a field by setting the strategic direction for the organization.
ASAP's Board members collectively hold decades of expertise in leading strategic partnerships in industries including technology, biopharmaceuticals, and healthcare. Their guidance ensures that ASAP remains at the forefront of alliance management as the discipline of effective partnership.
KATHERINE KENDRICK, CSAP, CA-AM
Executive Director,
Head of Alliance Management, Jazz Pharmaceuticals
(Term: July 2026-June 2028)
AIDA BENDT, CA-AM
Head of Alliance Management,
Oncology R&D, AstraZeneca
(Term: July 2026-June 2028)
NICOLE BOSTON, CAE, CA-AM
President & Chief Executive Officer, ASAP
(Term: Ex-officio)
BRENT HARVEY, CA-AM
Executive Director, Alliance Management, Eli Lilly and Company
(Term: July 2026-June 2028)
JAMIE DONALD, CSAP, CA-AM
Program Director Technology Partners, Axis Communications
(Term: July 2025-June 2027)
NANCY GRIFFIN, EDD, CSAP, CA-AM
Vice President, Program and Alliance Management, Valo Health
(Term: July 2026-June 2028)
CHRISTOPH HUWE, PHD, CSAP, CA-AM
Senior Director, Strategic Alliance Management, Bayer AG Pharmaceuticals
(Term: July 2026-June 2028)
PHILIP SAILER, CSAP, CA-AM
Executive Director, Storage Solutions Team, IBM
(Term: July 2026-June 2028)